LB Investment is a Seoul-based venture capital firm that focuses on early-stage investments, growth capital, mezzanine financing, and buyouts across diverse sectors. Their strategy targets industries such as biotech, life sciences, technology (including AI and semiconductors), healthcare, energy, consumer goods, and entertainment, primarily in South Korea and China, with some consideration for the US market.
Portfolio
3
Fund Size
$1.5B
Top Stage
Series B
Last 12 Mo
1
Stage Distribution
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Illimis Therapeutics | Series B | $42M | Jul 2025 |
| Nota | Series B | $14.7M | Oct 2021 |
| HappyFresh | Series D | $65M | Jul 2021 |
Top Co-Investors
STIC Investment1 shared
Z Venture Capital1 shared
DSC Investment1 shared
Aju IB1 shared
IMM Investment1 shared
GSR Ventures1 shared
InterVest1 shared
Last updated: 3 March 2026